Skip to main content
. 2017 Sep 27;8(50):87971–87979. doi: 10.18632/oncotarget.21313

Table 1. Patient group and demographic characteristics.

Factor Patient (n=168)
Age(≤60/>60) 32(19.0%)/136(81.0%)
Sex (male/female) 134(79.8%)/34(20.2%)
Smoking (no/yes) 72(42.9%)/96(57.1%)
Tumour site (Upper 1/3/Middle 1/3/Lower 1/3) 60(35.7%)/78(46.4%)/30(17.9%)
T stage (II/III/IV) 24(14.3%)/106(63.1%)/38(22.6%)
N stage (0/I) 44(26.2%)/124(73.8%)
Clinic stage (II/III/IV) 44(26.2%)/86(51.2%)/38(22.6%)
Adjuvant therapies (RT/CCRT) 46(27.4%)/122(72.6%)

RT: radical radiotherapy only; CCRT: concurrent chemoradiotherapy.